Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Inhibikase Therapeutics (IKT) Long-Term Debt Issuances (2020)

Historic Long-Term Debt Issuances for Inhibikase Therapeutics (IKT) over the last 1 years, with Q2 2020 value amounting to $27550.0.

  • Inhibikase Therapeutics' Long-Term Debt Issuances changed N/A to $27550.0 in Q2 2020 from the same period last year, while for Dec 2021 it was $27550.0, marking a year-over-year decrease of 8990.1%. This contributed to the annual value of $272800.0 for FY2020, which is N/A changed from last year.
  • Inhibikase Therapeutics' Long-Term Debt Issuances amounted to $27550.0 in Q2 2020.
  • In the past 5 years, Inhibikase Therapeutics' Long-Term Debt Issuances ranged from a high of $245250.0 in Q1 2020 and a low of $27550.0 during Q2 2020